What California chooses in the next six months will determine whether a decade of Medicaid transformation holds or collapses ...
Understanding the impact of price controls on drug research and approvals of secondary indications is critical for policy ...
The current MA risk adjustment model has shortcomings, both in predictive accuracy and payment equity across the Medicare ...
Since 1971, protection against measles, mumps, and rubella has been delivered in a single combined injection. A proposal to ...
Pediatrics is increasingly moving toward regionalized hub-and-spoke models organized around comprehensive “centers of ...
Three federal actions are putting intense pressure on the clinical dietetics workforce, just when it’s needed the most.
The administration is expected to appeal at least parts of the ruling, but the timing and scope of appeal is unclear. Meanwhile, HHS may offer flexibility on the current August 12 deadline for ...
Health Care Inflation Means Quality-Adjusted Price Growth, And Artificial Intelligence Can Reduce It
David Brailer’s June 11, 2026, commentary in Health Affairs Forefront describes how US health care payers and providers use ...
The premise of Medicaid as a policy laboratory rests on generating knowledge through rigorous evaluation. Yet, too often, ...
Recent evidence on cash transfers and child health is mixed, suggesting that cash transfers may be a necessary but ...
The Clover decision and resulting instability offer an opportunity to step back and assess how the Medicare Advantage quality ...
Under the FDA’s regulatory authority, drug companies, prescribers, and patients operate under one national standard for drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results